skip to Main Content
Constellation Brands to invest $5-billion to boost stake in Canopy Growth

Constellation Brands has signed a deal to invest $5-billion in Canopy Growth Corp. to increase its stake in the marijuana company to 38 per cent and make it its exclusive global cannabis partner.

Under the agreement, Constellation, a global producer of beer, wine and spirits, will acquire 104.5 million Canopy shares at a price of $48.60 per share.

Canopy shares surged more than 30 per cent in the first minutes of trading Wednesday in Toronto..

“Over the past year, we’ve come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy’s market-leading capabilities in this space,” Constellation Brands chief executive Rob Sands said in a statement.

“We look forward to supporting Canopy as they extend their recognized global leadership position in the medical and recreational cannabis space.”

The investment follows a deal last year that saw Constellation acquire a nearly 10 per cent stake in Canopy for $245-million.

The agreement Wednesday will see Constellation nominate four directors to Canopy Growth’s seven-member board of directors.

Constellation is also receiving 139.7 million new warrants, which are exercisable over the next three years. If Constellation exercises all of its existing and new warrants, its ownership in Canopy would exceed 50 per cent.

“Our business can now make the strategic investments required to accelerate our market position globally,” Canopy chairman and co-chief executive Bruce Linton said in a statement. [Read more @ The Globe and Mail]

This Post Has One Comment
  1. This will place Constellation in firm control of Canopy and the board. Job #1 will be to improve quality to meet existing standards and levels in the marketplace.

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

A Research-Driven Inquiry Into ‘Endotoxin On Cannabis’

About a month ago, Kevin McKernan, the founder and CSO of Massachusetts-based Medicinal Genomics, which also produces the CannMed conferences, posted online a rerecording of the Endotoxin on Cannabis presentation…

State treasurer racks up big legal bills in effort to remove cannabis chair

Massachusetts’ state treasurer has paid a private law firm hundreds of thousands of dollars as part of her months-long effort to suspend and potentially remove the chair of the state’s…

The exodus at NY’s Office of Cannabis Management continues

At least four high-ranking employees at New York’s Office of Cannabis Management have recently resigned their positions, a month after NY Cannabis Insider reported on other high-profile departures from the…

A year after legalization, where you can and can’t smoke pot in Minnesota is still a little hazy

Despite being legal for months, it was still kind of surreal to see people openly smoking marijuana in public recently, and smell the pungent clouds surrounding them. A small crowd…

More Categories

Back To Top
×Close search
Search